Valuation: Medicure Inc.

Market Cap 11.06M 7.82M 6.86M 6.36M 5.85M 749M 11.28M 75.76M 29.71M 368M 29.38M 28.74M 1.27B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 8.12M 5.74M 5.04M 4.66M 4.29M 550M 8.28M 55.6M 21.81M 270M 21.56M 21.09M 932M EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day-1.89%
1 week-1.89%
Current month-19.38%
1 month-2.80%
3 months-22.96%
6 months-11.86%
Current year-8.77%
1 week 1.04
Extreme 1.04
1.06
1 month 1
Extreme 1
1.29
Current year 0.85
Extreme 0.85
1.35
1 year 0.85
Extreme 0.85
1.43
3 years 0.63
Extreme 0.63
1.8
5 years 0.63
Extreme 0.63
1.8
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 14/09/1997
Director of Finance/CFO - 31/05/2022
Chief Tech/Sci/R&D Officer - 30/06/2019
Director TitleAgeSince
Chairman 79 14/09/1997
Director/Board Member 92 27/02/2000
Director/Board Member 56 21/01/2013
Date Insider Type Main position Quantity % Market Cap.
06-21Buy

Chief Executive Officer

1,000 0.0096%
06-21Buy

Chief Executive Officer

200 0.0019%
06-21Buy

Chief Executive Officer

2,500 0.0240%
Change 5-day change 1-year change 3-year change Capi.($)
-1.89%-1.89%-13.33%-19.38% 7.82M
-2.48%-3.13%+55.85%+89.65% 54.88B
-0.55%-6.57%+55.85%+128.31% 54.63B
-5.60%-2.19%+7.07%+420.24% 25.06B
-1.68%-4.32%-19.04%-17.93% 23.14B
-1.69%-0.64%+40.04%-0.48% 19.87B
+1.87%+4.16%+38.74%-26.42% 17.55B
-2.72%-0.60%+187.08%+351.91% 16.5B
-2.42%+1.00%+48.24%+635.77% 15.75B
-0.75%+0.57%+22.52%+188.60% 14.2B
Average -1.81%-2.52%+42.30%+175.03% 24.16B
Weighted average by Cap. -1.83%-1.56%+47.58%+165.87%

Financials

2024 2025
Net sales 21.91M 15.5M 13.59M 12.59M 11.58M 1.48B 22.33M 150M 58.84M 728M 58.19M 56.91M 2.52B 28.86M 20.41M 17.9M 16.58M 15.26M 1.95B 29.42M 198M 77.5M 959M 76.64M 74.96M 3.31B
Net income -1.04M -735K -645K -597K -549K -70.34M -1.06M -7.12M -2.79M -34.54M -2.76M -2.7M -119M -7.1M -5.02M -4.4M -4.08M -3.75M -480M -7.24M -48.6M -19.06M -236M -18.85M -18.44M -815M
Net Debt -6.32M -4.47M -3.92M -3.63M -3.34M -428M -6.44M -43.26M -16.97M -210M -16.78M -16.41M -725M -2.94M -2.08M -1.83M -1.69M -1.56M -199M -3M -20.16M -7.91M -97.87M -7.82M -7.65M -338M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
13/07/26 CA$1.040 -1.89% 1,000